Cannabinoids have been part of humanity’s medicine chest for almost as long as history has been recorded. Of all the negative consequences of prohibition, none is as tragic as the denial of the medicinal properties found in this plant to the millions of patients who could benefit from its use.
Cannabinoids have been part of humanity’s medicine chest for almost as long as history has been recorded. Of all the negative consequences of prohibition, none is as tragic as the denial of the medicinal properties found in this plant to the millions of patients who could benefit from its therapeutic use.
Modern research suggests that cannabinoids are a valuable aid in the treatment of a wide range of Active Clinical Studies. These include pain relief — particularly of neuropathic pain (pain from nerve damage) — nausea, spasticity, glaucoma, and movement disorders. It is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research and Studies suggests that the medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.
Currently, more than 60 U.S. and International Health Organizations support granting patients immediate legal access to cannabinoids under a physician’s supervision.
Clinical studies with single cannabinoids or whole plant preparations have often been inspired by positive anecdotal experiences of patients employing crude byproducts. The anti-emetic, the appetite enhancing, relaxing effects, analgesia, and therapeutic use in Tourette’s syndrome were all discovered in this manner.
Incidental observations have also revealed therapeutically useful effects. This occurred in a study with patients with Alzheimer’s disease wherein the primary issue was an examination of the appetite-stimulating effects of THC. Not only appetite and body weight increased, but disturbed behavior among the patients also decreased. The discovery of decreased intraocular pressure with THC administration in the beginning of the 1970s was also serendipitous. Additional interesting indications that have not been scientifically investigated, but remain common problems in modern medicine may benefit from cannabinoid treatment. For this reason, surveys have been conducted questioning individuals that use it therapeutically. They were conducted either as oral non-standardized interviews in the course of investigations of state or scientific institutions (House of Lords Select Committee on Science and Technology in the UK, Institute of Medicine in the USA) on the therapeutic potential or as anonymous surveys using standardized questionnaires.
My Compassion declares that it is the right of doctors to be able to discuss the medicinal use of cannabinoids with their patients.